1. Home
  2. BNTX vs DGX Comparison

BNTX vs DGX Comparison

Compare BNTX & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$91.52

Market Cap

24.2B

Sector

Health Care

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$197.71

Market Cap

22.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNTX
DGX
Founded
2008
1967
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.2B
22.6B
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
BNTX
DGX
Price
$91.52
$197.71
Analyst Decision
Strong Buy
Buy
Analyst Count
13
13
Target Price
$133.46
$214.38
AVG Volume (30 Days)
928.5K
689.6K
Earning Date
05-05-2026
04-21-2026
Dividend Yield
N/A
1.82%
EPS Growth
N/A
13.78
EPS
N/A
2.24
Revenue
N/A
$11,035,000,000.00
Revenue This Year
N/A
$7.53
Revenue Next Year
$3.37
$3.77
P/E Ratio
N/A
$89.44
Revenue Growth
N/A
11.78
52 Week Low
$79.81
$164.65
52 Week High
$124.00
$213.50

Technical Indicators

Market Signals
Indicator
BNTX
DGX
Relative Strength Index (RSI) 50.77 50.80
Support Level $90.67 $190.00
Resistance Level $95.14 $201.62
Average True Range (ATR) 2.61 4.47
MACD 0.46 0.28
Stochastic Oscillator 51.46 40.73

Price Performance

Historical Comparison
BNTX
DGX

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: